Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination.
McCormick
A L
AL
Dept. Medical Microbiology, University of Sheffield Medical School, United Kingdom.
Thomas
M S
MS
Heath
A W
AW
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D002460:Cell Line; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000096:biosynthesis / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology*; D008070:Lipopolysaccharides; D051379:Mice; D008808:Mice, Inbred CBA; D016133:Polymerase Chain Reaction; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000276:immunology; D014614:Vaccines, Synthetic
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D015699:HIV Envelope Protein gp120; D008070:Lipopolysaccharides; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D007371:Interferon-gamma